An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Patients With Generalized Myasthenia Gravis

NCT04980495 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
69
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

argenx